Refractive Surgery News

A guest editorial published in the Journal of Cataract & Refractive Surgery provided updated criteria for collecting, analyzing and reporting the outcomes of lens-based refractive surgery.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Michael Patterson, DO, discusses Johnson & Johnson’s OptiBlue violet light-filtering technology for multifocal IOLs.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Jay S. Pepose, MD, PhD, discusses advances in pharmacological treatment for reduction of pupil diameter, which may benefit patients with night vision disturbances.

A new AI-based model showed the ability to identify eyes with normal topographies at risk for developing post-LASIK ectasia.

Orasis Pharmaceuticals has submitted a new drug application to the FDA for CSF-1, its investigational eye drop candidate for presbyopia, according to a press release.

Throughout the year, eye care experts have shared their insights with Healio/OSN on a variety of topics.

None of us likes to have to tell a patient, “You are not a good candidate for LASIK.” When you do find yourself in this situation, you want to be certain you’re right.

This year’s top refractive surgery item was the announcement about the FDA approval of the STAAR Surgical EVO/EVO+ Visian ICL to treat myopia and myopia with astigmatism, complete with physician perspectives.

The final 2022 issue for the Video Journal of Cataract, Refractive, and Glaucoma Surgery, which focuses on training and educating ophthalmic surgeons through video-based lessons, is now online.

MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the AcrySof IQ Vivity and Vivity toric extended depth of focus lenses are a useful alternative, according to one specialist here.